Track topics on Twitter Track topics that are important to you
Cliff Holloway, CEO to Sienna Cancer Diagnostics, discusses the development and commercialisation of SCE-A7, the first telomerase detection product.
Bio-IT World | This summer, Foundation Medicine will launch what could be described as the next generation of cancer diagnostics. The Cambridge, Mass.-based company, founded by a premier group of can...
Louisville startup Breath Diagnostics has developed technology to pick up cancer-related compounds that are exhaled in one’s breath.
Recent advances have made diagnostic drug sensitivity testing for cancer a reality. What methods are currently available for drug sensitivity testing in gastric cancer diagnostics? Journal of Clinic...
by John Bennett MD We hosted a hangout with Shahriar Yaghoubi, Ph.D., MBA. Dr Yaghoubi has been doing pre-clinical and clinical research for over 20 years, now holding a position as CSO/Director of C...
What about PDL-1 in oncotherapy diagnostics for NSCLC? Larry H. Bernstein, MD, FCAP, Curator LPBI Questions on PD-L1 Diagnostics for Immunotherapy in NSCLC Alexander M. Castellino, PhD http://w...
Quest Diagnostics has agreed to make available Biocept's Target Selector mutation detection test for lung cancer in Mexico fo -More-
A step forward in diagnostics Larry H. Bernstein, MD, FCAP, Curator LPBI 3D Imaging of Cancer Cells Could Lead to Improved Ability of Pathologists and Radiologists to Plan Cancer Treatments and...
Single-cell proteomics in cancer is evolving and promises to provide more accurate diagnoses based on detailed molecular features of cells within tumors. This review focuses on technologies that allow...
Gastric cancer diagnostics has traditionally been histomorphological and primarily the domain of surgical pathologists. Although there is an increasing usage of molecular and genomic techniques for cl...
Companion diagnostics (CDx) have become a major tool in molecular pathology and assist in therapy decisions in an increasing number of various cancers. Particularly, the developments in lung cancer ha...
Gastric cancer is the fourth most common type of cancer and represents a major cause of cancer-related deaths worldwide. With recent biomedical advances in our understanding of the molecular character...
Early diagnostics of colorectal cancer is complicated by the lack of reliable serum biomarkers. This study aimed to investigate if the serum level of activin A can be used for diagnostics of this dise...